FDA clears Reponse Biomedical's respiratory syncytial virus test
This article was originally published in Clinica
Executive Summary
The US FDA has granted 510(k) clearance for Response Biomedical's respiratory syncytial virus (RSV) test. It will be marketed and sold by 3M Health Care as the 3M Rapid Detection RSV Test, and runs on Response's RAMP 200 Reader and 3M's Rapid Detection Reader.